A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects
Condition: Prostate Adenocarcinoma Intervention: Drug: Niraparib Pill Sponsor: Abramson Cancer Center of the University of Pennsylvania Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Gastroschisis Repair | Prostate Cancer | Research | University of Pennsylvania